SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001140361-22-019002
Filing Date
2022-05-13
Accepted
2022-05-13 09:01:08
Documents
70
Period of Report
2022-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q brhc10037352_10q.htm   iXBRL 10-Q 913778
2 EXHIBIT 10.1 brhc10037352_ex10-1.htm EX-10.1 69929
3 EXHIBIT 31.1 brhc10037352_ex31-1.htm EX-31.1 7593
4 EXHIBIT 31.2 brhc10037352_ex31-2.htm EX-31.2 7724
5 EXHIBIT 32.1 brhc10037352_ex32-1.htm EX-32.1 5295
  Complete submission text file 0001140361-22-019002.txt   5258181

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA ocup-20220331.xsd EX-101.SCH 50585
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE ocup-20220331_cal.xml EX-101.CAL 33167
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE ocup-20220331_def.xml EX-101.DEF 244874
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE ocup-20220331_lab.xml EX-101.LAB 585914
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ocup-20220331_pre.xml EX-101.PRE 375854
64 EXTRACTED XBRL INSTANCE DOCUMENT brhc10037352_10q_htm.xml XML 656201
Mailing Address 37000 GRAND RIVER AVE. SUITE 120 FARMINGTON HILLS MI 48335
Business Address 37000 GRAND RIVER AVE. SUITE 120 FARMINGTON HILLS MI 48335 248-681-9815
Ocuphire Pharma, Inc. (Filer) CIK: 0001228627 (see all company filings)

IRS No.: 113516358 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-34079 | Film No.: 22920461
SIC: 2834 Pharmaceutical Preparations